SensoDetect AB: SensoDetect technology in new doctoral thesis at Lund University
PhD student at the child and adolescent psychiatry at the University of Lund and chief physician Emma Claesdotter, defended on Friday her thesis "Auditory Brainstem Response (ABR) and Cambridge Neurophysiological Test Automated Battery (CANTAB) as Objective Support in Diagnosing Childhood ADHD and ASD". Claesdotter has examined children and adolescents with ADHD and ASD with SensoDetect technology in three studies.
Today's diagnosis of ADHD and autism (ASD) is based on the patient's medical history, psychological testing and assessment forms. These methods are not objective and can be affected by, for example, psychosocial factors. Emma Claesdotter has in the three studies examined children and adolescents with ADHD and ASD using SensoDetect technology. Associate Professor Tommy Lewander from Uppsala University was the opponent. The markers from Emma Claesdotter studies will be evaluated further in a blind study by the research team.
-ABR-technology is an exciting area and there is great need of objective markers of these situations (ADHD and ASD), says Emma Claesdotter, PhD and Cheif physician at Lund University Hospital, Sweden.
- It is very positive for both SensoDetect and of course for Emma that her doctoral thesis now is approved. It strengthens and increases the evidence and further possibilities', Says CEO Johan Olson, SensoDetect AB (publ.)